Former White House biosecurity official Raj Panjabi names the AI warning signs he watches for and the action each should trigger
Fortune · Public essay
Read the source (opens in a new tab)- What happened
- Raj Panjabi, White House senior director for global health security and biodefense from 2022 to 2023, wrote in Fortune on October 9, 2026 that the US has not agreed in advance what evidence of AI-enabled biological risk should set off which response.
- Key points
- He argues the threshold that matters next is "whether AI can carry a design from the digital world into the physical one," since a model that can write a protocol "is not a person who can create it."
- First sign: a person without advanced biological expertise using AI "to overcome experimental problems that previously required expert judgment," which he says requires independent red-teaming before deployment, "not voluntary company disclosures."
- Second: an AI-generated sequence of concern ordered from a synthesis provider or run through an automated lab, requiring watermarking and tracing tools for biological design systems, as the Bipartisan Commission on Biodefense recommended.
- Third: proof AI has cut the hands-on experience dangerous work needs; screening at synthesis providers, cloud labs and benchtop synthesizers "should be expanded; a bipartisan Senate bill has not moved since January."
- Evidence
- Signed commentary in Fortune, which notes such pieces are the author's own views. It is an argument for pre-agreed triggers, drawing on his National Security Council work and his seat on the Bipartisan Commission on Biodefense. He calls the White House accord on superintelligence an acknowledgment that biosecurity belongs at the center of the AI safety conversation, but says it leaves companies to decide when a risk is serious enough to act.